Cargando…
Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma
BACKGROUND: In this study, we investigated the relationship between clinicopathologic factors, BRAF(V600E) mutation status and [(18)F] F-fluoro-2-deoxyglucose (FDG) avidity in patients with radioiodine (RAI)-negative recurrent or metastatic differentiated thyroid cancer (DTC). METHODS: From 2015 to...
Autores principales: | Ha, Le Ngoc, Iravani, Amir, Nhung, Nguyen Thi, Hanh, Ngo Thi Minh, Hutomo, Febby, Son, Mai Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792294/ https://www.ncbi.nlm.nih.gov/pubmed/33413689 http://dx.doi.org/10.1186/s40644-020-00378-z |
Ejemplares similares
-
Screening and treatment of brain metastasis from papillary thyroid carcinoma: a case series
por: Ha, Le Ngoc, et al.
Publicado: (2023) -
Metastatic Follicular Thyroid Carcinoma Secreting Thyroid Hormone and Radioiodine Avid without Stimulation: A Case Report and Literature Review
por: Abid, Syed A., et al.
Publicado: (2014) -
False positive finding from malignancy-like lesions on FDG PET/CT: case report of tuberculosis patients
por: Hutomo, Febby, et al.
Publicado: (2020) -
Primary lung cancer with radioiodine avidity: A thyroid cancer cohort study
por: Lu, Yu-Ling, et al.
Publicado: (2021) -
Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using (18)F-FDG PET
por: Yoon, Joon-Kee, et al.
Publicado: (2019)